Commercializing the first ever wearable device delivering a safe, effective, and non-invasive treatment of cognitive decline from neurodegenerative diseases, such as Alzheimer’s Disease (AD), and improving brain health during aging. Multiple patents protect our technology. Human clinical studies, published in peer-reviewed journals, showed cognitive stabilization or improvement in 7 out of 8 AD sufferers. FDA Breakthrough Device Designation.